← FDA DRUG APPROVALS

FDA ANDA · ANDA201094

GLYDO

lidocaine hydrochloride

Sponsor: SAGENT PHARMS INC

APPLICATION
ANDA201094
TYPE
ANDA
ORIGINAL APPROVAL
2014-04-28
LATEST ACTION
2019-10-29
ROUTE
TOPICAL
DOSAGE FORM
JELLY
MARKETING STATUS
Prescription

Products

GLYDOPrescription
LIDOCAINE HYDROCHLORIDE 2% · JELLY · TOPICAL

Approval history

2019-10-29Labeling · Supplement 6 · standardAP
2014-04-28Not Applicable · OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →